Scott Burk
Internal Medicine · Great Falls, MTNPI 1538271465
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $938 and has fallen 87.5% since, to $117 in 2024. Among internal medicine clinicians in MT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 101 payments — averaging $14.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$187
- GSK$161
- AstraZeneca$140
- Pfizer$116
- Novo Nordisk$112
- AbbVie$107
- plus $627 from 15 others
What the payments were for
- Speaking & faculty fees$111%
- Food & beverage$1,43899%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 17 | $187 |
| GSK | 10 | $161 |
| AstraZeneca | 8 | $140 |
| Pfizer | 15 | $116 |
| Novo Nordisk | 8 | $112 |
| AbbVie(2 entities) | 5 | $107 |
| Amgen | 5 | $80 |
| E.r. Squibb & Sons, L.L.C. | 4 | $78 |
| Lilly USA, LLC | 4 | $72 |
| Johnson & Johnson | 5 | $65 |
| Exact Sciences | 3 | $51 |
| Astellas Pharma US Inc | 3 | $50 |
| Mylan Specialty L.p. | 2 | $44 |
| Sanofi Pasteur Inc. | 2 | $33 |
| Novartis | 2 | $32 |
| Boehringer Ingelheim | 2 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $26 |
| Ultragenyx Pharmaceutical Inc. | 1 | $22 |
| Dexcom, Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Acorda Therapeutics, Inc | 1 | $11 |
How this compares
$1,449 in reported general payments places this provider in the 90th percentile of 244 internal medicine providers in Montana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 173 | $131,678 |
| OzempicSemaglutide | 76 | $91,270 |
| JardianceEmpagliflozin | 91 | $86,628 |
| JanuviaSitagliptin Phosphate | 66 | $39,347 |
| FarxigaDapagliflozin Propanediol | 30 | $32,643 |
| XareltoRivaroxaban | 34 | $30,349 |
| MounjaroTirzepatide | 18 | $23,132 |
| MyrbetriqMirabegron | 41 | $15,904 |
| BelsomraSuvorexant | 20 | $8,927 |
| BrilintaTicagrelor | 25 | $7,653 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 12 | $7,614 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $7,296 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 202 | $6,067 |
| Tresiba Flextouch U-200Insulin Degludec | 11 | $5,822 |
| Atorvastatin Calcium | 387 | $4,380 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $116 | $131,678173 claims |
| Novo NordiskOzempic | $112 | $91,27076 claims |
| Boehringer IngelheimJardiance | $27 | $86,62891 claims |
| MerckJanuvia, Belsomra | $187 | $48,27486 claims |
| AstraZenecaFarxiga, Brilinta, Breztri Aerosphere | $140 | $47,59267 claims |
| Johnson & JohnsonXarelto | $65 | $30,34934 claims |
| Lilly USA, LLCMounjaro | $72 | $23,13218 claims |
| Astellas Pharma US IncMyrbetriq | $50 | $15,90441 claims |
| AbbVieSynthroid | $107 | $3,98343 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 244 internal medicine providers in Montana.
Other internal medicine in Great Falls
- Stacy KingslandGreat Falls$5K
- Nicholas TrumGreat Falls$2K
- Bradford BergmanGreat Falls$2K
- Steven ChrzanowskiGreat Falls$2K
- Kathleen BlairGreat Falls$1K
- Katherine ZitelloGreat Falls$682
- Eve GerasimouGreat Falls$661
- Berilonson OsiroGreat Falls$340
- James LeganGreat Falls$312
- Hanna BroniewskaGreat Falls$193
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.